Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Tops Revenue Estimates
IPSCCentury Therapeutics(IPSC) Zacks Investment Research·2024-05-09 21:40

Century Therapeutics, Inc. (IPSC) came out with a quarterly loss of 0.45pershareversustheZacksConsensusEstimateofalossof0.45 per share versus the Zacks Consensus Estimate of a loss of 0.50. This compares to loss of 0.53pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof100.53 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 10%. A quarter ago, it was expected that this company would post a loss of 0.56 per share when it actually produced a loss of $0.49, delivering a surprise of 12.50%. Over the last four quarters, the company ha ...